THE USE OF DICHLOROMETHYLENE BISPHOSPHONATE AND AMINOBUTANE BISPHOSPHONATE IN HYPERCALCEMIA OF MALIGNANCY

被引：0
|
作者：
ADAMI, S
BOLZICCO, GP
RIZZO, A
SALVAGNO, G
BERTOLDO, F
ROSSINI, M
SUPPI, R
LOCASCIO, V
机构：
来源：
BONE AND MINERAL | 1987年 / 2卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：395 / 404
页数：10
相关论文
共 50 条
  • [1] DOSE OF BISPHOSPHONATE FOR HYPERCALCEMIA OF MALIGNANCY
    MORTON, AR
    FRIEFELD, J
    HALPERIN, F
    LANCET, 1990, 335 (8703): : 1469 - 1470
  • [2] Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy
    Khan, Attiya A.
    Gurnani, Payal K.
    Peksa, Gary D.
    Whittier, William L.
    DeMott, Joshua M.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (03) : 277 - 285
  • [3] Malignancy-related hypercalcemia in the bisphosphonate era
    Alves, M. F. S.
    Mak, M. P.
    Piotto, G. H. M.
    Takahashi, T. K.
    Ramos, R. E. O.
    Fonseca, L. G.
    Silvino, M.
    Mano, M. S.
    Hoff, P. M.
    Castro, G., Jr.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S288 - S288
  • [4] Treatment of Bisphosphonate-Resistant Hypercalcemia of Malignancy with Calcitonin
    Dawson, Camilla
    Todd, Ann-Marie
    Walton, Abigail
    JOURNAL OF PALLIATIVE MEDICINE, 2014, 17 (10) : 1084 - 1084
  • [5] Zoledronic acid - A bisphosphonate for hypercalcemia of malignancy and osteolytic metastases
    Massaro, AM
    CANCER PRACTICE, 2002, 10 (04) : 219 - 221
  • [6] The use of zoledronic acid, a novel, highly potent bisphosphonate, for the treatment of hypercalcemia of malignancy
    Major, P
    ONCOLOGIST, 2002, 7 (06): : 481 - 491
  • [7] Denosumab for the treatment of bisphosphonate-refractory hypercalcemia of malignancy (HCM).
    Hu, Mimi I-Nan
    Glezerman, Ilya
    Leboulleux, Sophie
    Insogna, Karl L.
    Gucalp, Rasim A.
    Misiorowski, Waldemar
    Yu, Bennett Winston
    Zorsky, Paul
    Tosi, Diego
    Bessudo, Alberto
    Jaccard, Arnaud
    Tonini, Giuseppe
    Wang, Huei
    Braun, Ada
    Jain, Rajul K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Malignancy-related hypercalcemia developing on a bisphosphonate but responding to calcitonin
    Diskin, Charles J.
    Stokes, Thomas J.
    Dansby, Linda A.
    Radcliff, Lautrec
    Carter, Thomas B.
    CLINICAL LUNG CANCER, 2007, 8 (07) : 434 - 435
  • [9] TREATMENT OF BONE METASTASES WITH DICHLOROMETHYLENE BISPHOSPHONATE
    FRANCINI, G
    GONNELLI, S
    PETRIOLI, R
    CONTI, F
    PAFFETTI, P
    GENNARI, C
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) : 591 - 598
  • [10] Combined therapies with calcitonin and corticosteroids, or bisphosphonate, for treatment of hypercalcemia of malignancy
    Wimalawansa S.J.
    Journal of Bone and Mineral Metabolism, 1997, 15 (3) : 160 - 164
12345